AAAAAA
Results:
1-17
|
Results: 17
Authors:
Chambers, CA
Kuhns, MS
Egen, JG
Allison, JP
Citation: Ca. Chambers et al., CTLA-4-mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy, ANN R IMMUN, 19, 2001, pp. 565-594
Authors:
Dong, C
Juedes, AE
Temann, UA
Shresta, S
Allison, JP
Ruddle, NH
Flavell, RA
Citation: C. Dong et al., ICOS co-stimulatory receptor is essential for T-cell activation and function, NATURE, 409(6816), 2001, pp. 97-101
Authors:
Sullivan, TJ
Letterio, JJ
van Elsas, A
Mamura, M
van Amelsfort, J
Sharpe, S
Metzler, B
Chambers, CA
Allison, JP
Citation: Tj. Sullivan et al., Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation, P NAS US, 98(5), 2001, pp. 2587-2592
Authors:
Sutmuller, RPM
van Dulvenvoorde, LM
van Elsas, A
Schumacher, TNM
Wildenberg, ME
Allison, JP
Toes, REM
Offringa, R
Melief, CJM
Citation: Rpm. Sutmuller et al., Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses, J EXP MED, 194(6), 2001, pp. 823-832
Authors:
van Elsas, A
Sutmuller, RPM
Hurwitz, AA
Ziskin, J
Villasenor, J
Medema, JP
Overwijk, W
Restifo, NP
Melief, CJM
Offringa, R
Allison, JP
Citation: A. Van Elsas et al., Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: Comparison of prophylaxis and therapy, J EXP MED, 194(4), 2001, pp. 481-489
Authors:
Allison, JP
Citation: Jp. Allison, Cancer - Editorial overview, CURR OP IM, 12(5), 2000, pp. 569-570
Authors:
Piganelli, JD
Poulin, M
Martin, T
Allison, JP
Haskins, K
Citation: Jd. Piganelli et al., Cytotoxic T lymphocyte antigen 4 (CD152) regulates self-reactive T cells in BALB/c but not in the autoimmune NOD mouse, J AUTOIMMUN, 14(2), 2000, pp. 123-131
Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells
Authors:
Luhder, F
Chambers, C
Allison, JP
Benoist, C
Mathis, D
Citation: F. Luhder et al., Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells, P NAS US, 97(22), 2000, pp. 12204-12209
Authors:
Yu, X
Fournier, S
Allison, JP
Sharpe, AH
Hodes, RJ
Citation: X. Yu et al., The role of B7 costimulation in CD4/CD8 T cell homeostasis, J IMMUNOL, 164(7), 2000, pp. 3543-3553
Authors:
Hurwitz, AA
Foster, BA
Kwon, ED
Truong, T
Choi, EM
Greenberg, NM
Burg, MB
Allison, JP
Citation: Aa. Hurwitz et al., Combination immunotherapy of primary prostate cancer in a transgenic mousemodel using CTLA-4 blockade, CANCER RES, 60(9), 2000, pp. 2444-2448
Authors:
Chambers, CA
Allison, JP
Citation: Ca. Chambers et Jp. Allison, Costimulatory regulation of T cell function, CURR OP CEL, 11(2), 1999, pp. 203-210
Authors:
Chambers, CA
Allison, JP
Citation: Ca. Chambers et Jp. Allison, CTLA-4 - The costimulatory molecule that doesn't: Regulation of T-cell responses by inhibition, COLD S HARB, 64, 1999, pp. 303-312
Authors:
Kwon, ED
Foster, BA
Hurwitz, AA
Madias, C
Allison, JP
Greenberg, NM
Burg, MB
Citation: Ed. Kwon et al., Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy, P NAS US, 96(26), 1999, pp. 15074-15079
Authors:
Sotomayor, EM
Borrello, I
Tubb, E
Allison, JP
Levitsky, HI
Citation: Em. Sotomayor et al., In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance, P NAS US, 96(20), 1999, pp. 11476-11481
Authors:
Chambers, CA
Kuhns, MS
Allison, JP
Citation: Ca. Chambers et al., Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses, P NAS US, 96(15), 1999, pp. 8603-8608
Authors:
Brunner, MC
Chambers, CA
Chan, FKM
Hanke, J
Winoto, A
Allison, JP
Citation: Mc. Brunner et al., CTLA-4-mediated inhibition of early events of T cell proliferation, J IMMUNOL, 162(10), 1999, pp. 5813-5820
Authors:
van Elsas, A
Hurwitz, AA
Allison, JP
Citation: A. Van Elsas et al., Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous andmetastatic tumors accompanied by autoimmune depigmentation, J EXP MED, 190(3), 1999, pp. 355-366
Risultati:
1-17
|